Public health and physician cluster...

Public health and physician clusters have recommended that health care providers increase the number of doses of pneumococcal conjugate vaccine administered to healthy children from sum of two units to three, according to a July 8 2004 moderns release from the Centers for Disease hinder and Prevention (CDC). Production question s in early 2004 caused shortages of the vaccine, prompting the CDC to render the recommended four doses to sum of two units to use the Limited available doses chiefly effectively.

The CDC the Advisory Committee in succession Immunization Practices, the American Academy of Family Physicians, and the American Academy of Pediatrics also commend that health care providers continue to administer the satiated four-dose series of the vaccine to children up to 15 month of age with health conditions in the same state [i]or[/i] condition as sickle cell anemia or immune regularity disorders, who are at increased risk of inexorable disease. The groups said providers should delay the fourth dose of the vaccine for healthy children until production and give data demonstrate that vaccine supplies are adequate for routine administration of the four-dose series.

Pneumococcal infection can cause serious illness and level death. The vaccine can help obstruct serious pneumococcal diseases, including meningitis and children infections. In the United States, invasive pneumococcal disease is the Leading cause of bacterial meningitis, for which children younger than couple years of age are at highest risk. Before a vaccine was available, pneumococcal infection caused more than 700 cases of meningitis, 13000 kin infections, and approximately five million ear infections each year.

In February 2004 the CDC commited suspension of the fourth dose of pneumococcal conjugate vaccine when it Learned that the manufacturer would not be able to effect enough vaccine to meet demand. In March, it became clear that production would be curtailed for several month and the CDC commended that the third dose also be withheld.

The vaccine normally is attract favor toed for young children in a four-dose schedule: single dose each at two month four month and six month of age, and a final dose between 12 and 15 month of age. This recommendation reinstates the third dose that usually is administered at six month for healthy children. The vaccine is not routinely make acceptableed for children older than sum of two units years of age.

The public health and medical clumps also have recommended a catch-up schedule for children who missed the third dose. Children at high risk for invasive pneumococcal disease are the highest priority for catch-up vaccination. Vaccination of healthy children younger than 24 month of age who have not received any doses of pneumococcal conjugate vaccine is the next to the first priority. Vaccination of healthy children younger than 12 month of age who have not besides received three doses of the vaccine is the third priority.

Health clumps Reinstate Recommendation for Third Dose of Pediatric Pneumococcal Conjugate Vaccine (Prevnar[R]) (new release, Atlanta: Center for Disease curb and Prevention, July 8, 2004) http://wwwcdcgov/od/oc /media/pressrel/r040708.htm (accessed 3 Aug 2004)

COPYRIGHT 2004 Association of Operating apartment Nurses, Inc.

COPYRIGHT 2004 Gale Group